PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
40.53%
Revenue growth 1.25-1.5x VET's 27.70%. Bruce Berkowitz would examine if growth advantage is sustainable.
13.44%
Cost growth 1.1-1.25x VET's 10.81%. Bill Ackman would demand evidence of cost control initiatives.
68.72%
Gross profit growth 1.25-1.5x VET's 48.73%. Bruce Berkowitz would examine sustainability.
20.06%
Margin expansion 1.25-1.5x VET's 16.47%. Bruce Berkowitz would examine sustainability.
No Data
No Data available this quarter, please select a different quarter.
10.18%
G&A growth less than half of VET's 23.04%. David Dodd would verify if efficiency advantage is structural.
No Data
No Data available this quarter, please select a different quarter.
-136.36%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
5.63%
Operating expenses growth less than half of VET's 11.29%. David Dodd would verify sustainability.
9.60%
Similar total costs growth to VET's 11.02%. Walter Schloss would investigate norms.
-5.94%
Interest expense reduction while VET shows 2.31% growth. Joel Greenblatt would examine advantage.
15.71%
D&A growth above 1.5x VET's 6.91%. Michael Burry would check for excessive investment.
-39.19%
EBITDA decline while VET shows 27.86% growth. Joel Greenblatt would examine position.
190.42%
EBITDA margin growth exceeding 1.5x VET's 9.40%. David Dodd would verify competitive advantages.
6650.00%
Operating income growth exceeding 1.5x VET's 269.82%. David Dodd would verify competitive advantages.
4760.79%
Operating margin growth exceeding 1.5x VET's 189.60%. David Dodd would verify competitive advantages.
-121.86%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-71.84%
Pre-tax income decline while VET shows 68.71% growth. Joel Greenblatt would examine position.
-79.96%
Pre-tax margin decline while VET shows 75.50% growth. Joel Greenblatt would examine position.
64.91%
Tax expense growth while VET reduces burden. John Neff would investigate differences.
-177.89%
Net income decline while VET shows 122.06% growth. Joel Greenblatt would examine position.
-155.43%
Net margin decline while VET shows 117.27% growth. Joel Greenblatt would examine position.
-178.67%
EPS decline while VET shows 122.19% growth. Joel Greenblatt would examine position.
-178.67%
Diluted EPS decline while VET shows 121.88% growth. Joel Greenblatt would examine position.
-0.04%
Share count reduction while VET shows 0.92% change. Joel Greenblatt would examine strategy.
No Data
No Data available this quarter, please select a different quarter.